Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib
| Data(s) |
01/01/2006
|
|---|---|
| Identificador | |
| Idioma(s) |
eng |
| Publicador |
National Institute of Clinical Studies |
| Palavras-Chave | #EX #320501 Pharmaceutical Sciences and Pharmacy #730114 Skeletal system and disorders (incl. arthritis) |
| Tipo |
Conference Paper |